New NIAID Radiation and Nuclear Countermeasures Program’s DAIT Council-Approved Research Concepts (January 27, 2014)
BAA-13-100-SOL-00013: Advanced Research and Development of Chemical, Biological, Radiological, and Nuclear Medical Countermeasures for BARDA. Posted July 31, 2013
BAA-13-100-SOL-00014: Science and Technology Platforms Applied to Medical Countermeasure Development (Innovations) for BARDA. Posted July 31, 2013
The Armed Forces Radiobiology Research Institute (AFRRI) has served as the lead agency for research in radiation biology for the operational and medical support of Department of Defense (DOD) services. The relative importance of radiobiology research waned over the past decade, however, and no federal agency has ever had primary responsibility for the development of radiation countermeasures for the civilian population, whose needs are significantly different from those of the military. Thus, the current cadre of investigators conducting research into medical countermeasures for radiological injury is small, the infrastructure to support such research is inadequate, and only a few small training programs in the radiological health sciences exist. Moreover, the physical infrastructure and other support (e.g., biostatistical services, GLP-certified facilities) are limited for high-quality basic and translational research and are particularly lacking for development and licensure of experimental dosimetry and radiological countermeasures.
The primary mechanism to support infrastructure enhancement will be the Centers for Medical Countermeasures Against Radiation program, which will help to expand both physical and human infrastructure devoted to radiation countermeasures research. Examples of support to be provided by the research centers program, as well as other programs in this area, include
back to top
Last Updated September 19, 2005